Search details
1.
Scoring system for optimal cord blood unit selection for single cord blood transplantation.
Cytotherapy
; 26(3): 286-298, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38149949
2.
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
Ann Hematol
; 103(1): 285-296, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37947825
3.
Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Blood
; 138(17): 1628-1636, 2021 10 28.
Article
in English
| MEDLINE | ID: mdl-34269803
4.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33104215
5.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-36779595
6.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35443559
7.
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.
Ann Hematol
; 102(6): 1549-1559, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37126115
8.
NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation.
Am J Respir Crit Care Med
; 203(12): 1533-1545, 2021 06 15.
Article
in English
| MEDLINE | ID: mdl-33523764
9.
Effect of Cytomegalovirus Reactivation With or Without Acute Graft-Versus-Host Disease on the Risk of Nonrelapse Mortality.
Clin Infect Dis
; 73(3): e620-e628, 2021 08 02.
Article
in English
| MEDLINE | ID: mdl-33341890
10.
Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.
Cancer Sci
; 112(1): 331-338, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33075165
11.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Article
in English
| MEDLINE | ID: mdl-33085090
12.
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Br J Haematol
; 192(3): 531-541, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32583431
13.
Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group.
Ann Hematol
; 100(12): 3029-3038, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34490500
14.
[Respiratory virus infections after hematopoietic cell transplantation].
Rinsho Ketsueki
; 62(8): 1288-1295, 2021.
Article
in Japanese
| MEDLINE | ID: mdl-34497218
15.
Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or Type.
Biol Blood Marrow Transplant
; 26(7): 1363-1370, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32311477
16.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32062061
17.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
18.
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biol Blood Marrow Transplant
; 26(6): 1210-1217, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32088366
19.
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 26(3): 472-479, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31669399
20.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 26(3): 553-561, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31726205